Holen Sie sich die Stockscreener-App
84.69
1.77%
-1.53
Handel nachbörslich:
84.69
Schlusskurs vom Vortag:
$86.22
Offen:
$86.94
24-Stunden-Volumen:
523.46K
Relative Volume:
1.24
Marktkapitalisierung:
$2.94B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-91.00M
KGV:
-23.08
EPS:
-3.67
Netto-Cashflow:
$-74.38M
1W Leistung:
-5.53%
1M Leistung:
+24.95%
6M Leistung:
+71.06%
1J Leistung:
+79.69%
1-Tages-Spanne:
$83.40
$87.50
1-Wochen-Bereich:
$83.40
$89.79
52-Wochen-Spanne:
$30.82
$95.95
Disc Medicine Inc Stock (IRON) Company Profile
Firmenname
Disc Medicine Inc
Sektor
Branche
Telefon
(617) 674-9274
Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN
Vergleichen Sie IRON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
84.69 | 3.22B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-11 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-17 | Eingeleitet | Raymond James | Outperform |
| 2023-04-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Eingeleitet | Stifel | Buy |
| 2023-04-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-03-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Disc Medicine to present initial DISC-0974 data from RALLY-MF trial - Investing.com
Disc Medicine (NASDAQ: IRON) to present RALLY-MF Phase 2 data at ASH with JAK combos - Stock Titan
What makes Disc Medicine Inc. stock attractive to growth fundsJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
IRON: Stifel Reinstates 'Buy' Rating with New Price Target of $1 - GuruFocus
How to escape a deep drawdown in Disc Medicine Inc.2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
Disc Medicine (IRON) Receives Buy Rating with Promising Outlook - GuruFocus
Is Disc Medicine Inc. stock attractive for passive investorsMarket Risk Analysis & Weekly High Potential Stock Alerts - newser.com
How sustainable is Disc Medicine Inc. stock dividend payoutQuarterly Portfolio Summary & AI Powered Market Entry Ideas - newser.com
Is Disc Medicine Inc. stock trading near support levels2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
Is Disc Medicine Inc. stock in correction or buying zoneGold Moves & Low Drawdown Trading Strategies - newser.com
Can Disc Medicine Inc. stock weather global recession2025 Key Lessons & Growth Focused Entry Reports - newser.com
Will Disc Medicine Inc. stock maintain growth storyJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - newser.com
How Disc Medicine Inc. stock performs in interest rate cyclesJuly 2025 Movers & Safe Entry Point Identification - newser.com
Why Disc Medicine Inc. stock is considered a top pickExit Point & Entry Point Confirmation Signals - newser.com
Applying Wyckoff theory to Disc Medicine Inc. stockJuly 2025 Earnings & Capital Efficiency Focused Ideas - newser.com
Morgan Stanley Issues Positive Forecast for Disc Medicine (NASDAQ:IRON) Stock Price - MarketBeat
Disc Medicine stock reiterated Strong Buy at Raymond James on DISC-0974 potential - Investing.com
Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Disc Medicine (IRON) and Baxter International (BAX) - The Globe and Mail
Disc Medicine to Participate in Upcoming Investor Conferences - Enidnews.com
Disc Medicine (NASDAQ: IRON) to appear at Guggenheim, Stifel, Jefferies; live webcasts - Stock Titan
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
What valuation multiples suggest for Disc Medicine Inc. stockEarnings Growth Summary & Real-Time Chart Breakout Alerts - newser.com
WilmerHale Advises Underwriters in $287.5 Million Public Offering of Disc Medicine - WilmerHale
IRON Stock: Morgan Stanley Raises Price Target to $115 | IRON St - GuruFocus
Morgan Stanley Raises Price Target on Disc Medicine to $115 From $90, Keeps Overweight Rating - MarketScreener
Disc Medicine’s Promising Anemia Treatment Study: Key Insights for Investors - MSN
Chronic Kidney Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Jiangsu HengRui, Disc Medicine, 3SBio, Kind Pharma, Jiangsu Hansoh Pharm - Barchart.com
Disc Medicine (IRON): Evaluating Valuation After New Clinical Trial Plans and FDA Recognition Boost Pipeline Momentum - Yahoo Finance
Disc Medicine, Inc. (IRON) stock forecast and price target - Yahoo! Finance UK
Disc Medicine planning trial of iron overload treatment for sickle cell - Sickle Cell Disease News
Aug Chart Watch: Why Disc Medicine Inc. stock is considered a top pickQuarterly Earnings Summary & Daily Entry Point Trade Alerts - fcp.pa.gov.br
Why Disc Medicine Inc. stock remains a top recommendationWeekly Trading Summary & Accurate Intraday Trade Tips - fcp.pa.gov.br
Top chart patterns to watch in Disc Medicine Inc.July 2025 Breakouts & Consistent Profit Focused Trading Strategies - newser.com
Why Disc Medicine Inc. stock remains on watchlistsWeekly Market Outlook & Free Community Consensus Stock Picks - fcp.pa.gov.br
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):